Epigral Ltd

NSE: EPIGRAL · BSE: 543332 · Chemicals & Petrochemicals · 9 announcements

Share price: ₹1,060.60
Market cap: ₹4,576 Cr
Revenue (annual): ₹2,527 Cr
Net profit (annual): ₹332.0 Cr
P/E (TTM): 16.9×Sector 37.5×
Promoter holding: 68.83%+0.00% QoQ
FII holding: 1.03%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 2 Financial Results 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

27 Jul 2026 22:22 IST BSE

Earnings Call

Epigral Earnings Call Transcript: Key Takeaways

Epigral reported 15% revenue growth and 25% EBITDA margins despite Red Sea logistical disruptions. Management is pivoting toward high-value downstream specialty chemicals like Epoxy resins to reduce commodity exposure.

Call: Guides 20% growth

Open call summary → Read the filing ↗

27 Jul 2026 14:14 IST BSE

Earnings Call

Epigral Investor Presentation: Key Takeaways

Epigral reported 15% YoY revenue growth and 25% PAT growth for Q1FY27. Strategy focuses on diversifying into high-value derivatives and specialty chemicals with significant capex for Epoxy Resin and Multi-Purpose plants.

Call: Guides 70% growth

Open call summary → Read the filing ↗